1. Home
  2. CVKD vs UPC Comparison

CVKD vs UPC Comparison

Compare CVKD & UPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • UPC
  • Stock Information
  • Founded
  • CVKD 2022
  • UPC N/A
  • Country
  • CVKD United States
  • UPC China
  • Employees
  • CVKD N/A
  • UPC N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • UPC Biotechnology: Pharmaceutical Preparations
  • Sector
  • CVKD Health Care
  • UPC Health Care
  • Exchange
  • CVKD Nasdaq
  • UPC Nasdaq
  • Market Cap
  • CVKD 8.2M
  • UPC 13.0M
  • IPO Year
  • CVKD 2023
  • UPC 2021
  • Fundamental
  • Price
  • CVKD $0.43
  • UPC $3.70
  • Analyst Decision
  • CVKD Strong Buy
  • UPC
  • Analyst Count
  • CVKD 2
  • UPC 0
  • Target Price
  • CVKD $3.50
  • UPC N/A
  • AVG Volume (30 Days)
  • CVKD 71.6K
  • UPC 137.1K
  • Earning Date
  • CVKD 08-12-2024
  • UPC 07-30-2024
  • Dividend Yield
  • CVKD N/A
  • UPC N/A
  • EPS Growth
  • CVKD N/A
  • UPC N/A
  • EPS
  • CVKD N/A
  • UPC N/A
  • Revenue
  • CVKD N/A
  • UPC $32,308,735.00
  • Revenue This Year
  • CVKD N/A
  • UPC N/A
  • Revenue Next Year
  • CVKD N/A
  • UPC N/A
  • P/E Ratio
  • CVKD N/A
  • UPC N/A
  • Revenue Growth
  • CVKD N/A
  • UPC N/A
  • 52 Week Low
  • CVKD $0.36
  • UPC $0.75
  • 52 Week High
  • CVKD $2.17
  • UPC $4.32
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 40.00
  • UPC 62.26
  • Support Level
  • CVKD $0.43
  • UPC $2.87
  • Resistance Level
  • CVKD $0.49
  • UPC $4.11
  • Average True Range (ATR)
  • CVKD 0.02
  • UPC 0.50
  • MACD
  • CVKD -0.00
  • UPC 0.05
  • Stochastic Oscillator
  • CVKD 0.17
  • UPC 68.43

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

Share on Social Networks: